Special Issue

Topic: Immunotherapy Of Cancer: Future Possible Therapy For Metastatic Cancer

A Special Issue of Journal of Cancer Metastasis and Treatment

ISSN 2454-2857 (Online) 2394-4722 (Print)

Submission deadline: 31 Jan 2020

Guest Editor(s)

Dr. Pravin D. Potdar
Professor of Genetics and Stem cell Research, Dr. A.P.J Abdul Kalam Education & Research Centre, Mumbai, India.

Special Issue Introduction

Cancer is one of the most common leading cause of death in men and women worldwide. Most of the cancers are diagnosed at the last stage. Therefore, clinicians find difficulty in giving treatment to these patients which resulted in an overall high mortality rate in cancer patients. Radiation therapy or chemotherapy is the major treatment for most of the cancers. However, due to severe side effects, most of the cancer patients stumble to death. Immunotherapy is an alternative innovative therapy for cancer, which uses cancer patient's own body cells to stimulate their own immune system to kill cancer cells. There are different types of immunotherapies such as treatment of cancer patients with monoclonal antibodies, cancer vaccine, immune-check points inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapies. CAR T-cell therapy is one of the promising therapies, where immune T cells are modified in the lab in such a way that they can destroy cancer cells alone leaving normal cells live. Few CAR T-cell therapies are approved for use in the treatment of advanced leukemia and lymphomas. CAR T-cell therapies are only being used in clinical trials for those patients who are not responding to conventional therapy. In 2018, Professor James Allison from M.D. Anderson Cancer Centre, Texas, USA, received the Noble prize for his outstanding contribution in the field of immunotherapy of cancer. Since then, there is great excitement in the field immunotherapy of cancer. Therefore, the Journal of Cancer Metastasis and Treatment (JCMT) has the great privilege to introduce this important hot topic for their readers through this Special Issue on "Immunotherapy of Cancer - Future Possible Therapy for Metastatic Cancer." This issue will address important technical and theoretical aspects of the development of immunotherapy for various cancers. This Special Issue will also emphasize its early clinical drug development, clinical trials, translational research, therapeutic effectiveness and successful management for the treatment of cancer patients. This Special Issue will be a great asset and reference book for young cancer researchers, who are beginning their research on these novel therapies of cancer.

Keywords

Immunotherapy, cancer, CAR-T cells, monoclonal antibody, Immune T cells, cancer metastasis

Submission Deadline

31 Jan 2020

Submission Information

For Author Instructions, please refer to https://www.oaepublish.com/jcmt/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=jcmt&SpecialIssueId=291
Submission Deadline: 31 Jan 2020
Contacts: Lijun Jin, managing editor, editorialoffice@jcmtjournal.com

Published Articles

Special issue on “Immunotherapy of cancer: future possible therapy for metastatic cancer”

Open Access Editorial DOI: 10.20517/2394-4722.2020.75 26 Sep 2020
Views: Downloads:
Download PDF

Cyclophosphamide, fluorouracil and low-dose interleukin-2 and salvage combination chemotherapy in advanced cutaneous squamous cell carcinoma

Open Access Case Report DOI: 10.20517/2394-4722.2020.11 23 Jun 2020
Views: Downloads:
Download PDF

Multi-layered control of PD-L1 expression in Epstein-Barr virus-associated gastric cancer

Open Access Review DOI: 10.20517/2394-4722.2020.12 22 May 2020
Views: Downloads:
Download PDF

Development of a Functional Assessment of Chronic Illness Therapy item library and primary symptom list for the assessment of patient-reported adverse events associated with immune checkpoint modulators

Open Access Original Article DOI: 10.20517/2394-4722.2019.38 12 Mar 2020
Views: Downloads:
Download PDF

Physical exercise in locally advanced pancreatic adenocarcinoma: “If I walk, I live. Although one can die of cancer, now I am living”

Open Access Case Report DOI: 10.20517/2394-4722.2019.30 16 Dec 2019
Views: Downloads:
Download PDF

Lectin-like transcript 1 as a natural killer cell-mediated immunotherapeutic target for triple negative breast cancer and prostate cancer

Open Access Review DOI: 10.20517/2394-4722.2019.29 16 Dec 2019
Views: Downloads:
Download PDF

Novel immunotherapeutic approaches in head and neck cancer

Open Access Review DOI: 10.20517/2394-4722.2019.32 21 Nov 2019
Views: Downloads:
Download PDF

CXCR4 signalling, metastasis and immunotherapy: zebrafish xenograft model as translational tool for anti-cancer discovery

Open Access Review DOI: 10.20517/2394-4722.2019.022 7 Nov 2019
Views: Downloads:
Download PDF

Head and neck cancer and immunotherapy: current knowledge and perspective

Open Access Review DOI: 10.20517/2394-4722.2019.023 29 Oct 2019
Views: Downloads:
Download PDF
Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/